T cell immunity in malaria

Indian Journal of Medical Research

Volumn 106, Issue AUG., 1997, Pages 130-148

  Kabilan, Lalitha ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Immune responses; Malaria; T cell

Indexed keywords

ANTIGEN; MALARIA VACCINE; PARASITE ANTIBODY;

ANTIGEN RECOGNITION; B LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE COURSE; IMMUNITY; MALARIA; REVIEW; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; MALARIA; PLASMODIUM; T-LYMPHOCYTES;

EID: 0030868768     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Sharma VP. Ecosystem approach to malaria control. Proc Natl Acad Sci India 1993; 63(B) : 47-51.
2. Baird JK. Age and 'Strain transcending' immunity to Plasmodium falciparum. Parasitol Today 1994; 10 : 302.
3. Roberts DJ, Newbold CI, Biggs BA, Brown G. Age and "Strain transcending" immunity to Plasmodium falciparum. Parasitol Today 1994; 10 : 303.
4. Boudin C. Sheick I, Chumpitazi B, Pazart L, Högh B, Peyron F, Deloron P, Picot S, et al. The multifactorial and multistage character of protective immunity to Plasmodium falciparum, naturally acquired by an indigenous population in Burkina Faso. Scand J Immunol 1994; 39:409-17.
5. Troye-Blomberg M, Perlmann P. T cell functions in Plasmodium falciparum malarias. Prog Allergy 1988; 41 : 253-87.
6. Weidanz WP, Long CA. The role of T cells in immunity to malaria. Prog Allergy 1988; 41 : 215-52.
7. Cavacini LA, Parke LA, Weidanz WP. Resolution of acute malarial infections by T cell dependent non-antibody-mediated mechanisms of immunity. Infect Immun 1990; 58 : 2946-50.
8. Sabchareon A, Burnouf T, Ouattara D. Attanath P, Bouheroun-Tayoun MB, Chantavanich P, et al. Parasitological and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991; 45:297-308.
9. Kabilan L, Troye-Blomberg M, Patarroyo ME, Björkman A. Perlmann P. Regulation of the immune response in Plasmodium falciparum malaria:IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clin Exp Immunol 1987; 68:288-97.
10. White WI, Evans CB, Taylor DW. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitaemias in mice infected with Plasmodium yoelii. Infect Immun 1991; 59 : 3547-54.
11. Watier H, Verwaerde C. Landau I. Werner L. Fontaine J. Capron A, et al. T-cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi. Infect Immun 1992; 60 : 136-42.
12. Vinetz JM, Kumar S, Good MF, Fowlkes BJ, Berzofsky JA, Miller LH. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. J Immunol 1990; 144:1069-74.
13. Kumar S, Miller LH. Cellular mechanisms in immunity to blood stage infection. Immunol Lett 1990; 25:109-14.
14. Romero P, Maryanski JL, Corradin G, Nussenzweig RS. Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989; 341:323-6.
15. Stevenson MM, Tam MF, Rae D. Dependence on cell-mediated mechanisms for the appearance of crisis forms during Plasmodium chabaudi AS infection in C57BL/6 mice. Microb Pathol 1990; 9: 303-14.
16. Migot F, Millet P, Chougnet C, Lepers JP, Deloron P. Humoral and cellular immune responses to the circumsporozoite protein of Plasmodium vivax in Madagascar. Am J Trop Med Hyg 1993; 48:524-9.
17. Wahlgren M, Bejarano M-T, Troye-Blomberg M. Perlmann P, Riley EM, Greenwood BM et al. Epitopes of the Plasmodium falciparum clustered-asparagine-rich protein (CARP) recognized by human T-cells and antibodies. Parasite Immunol 1991; 13 : 681-94.
18. Kabilan L, Sharma VP, Kaur P, Ghosh SK, Yadav RS, Chauhan VS. Cellular and humoral immune responses to well defined blood stage antigens (Major merozoite surface antigen) of P. falciparum in adults from an Indian zone where malaria is endemic. Infect Immun 1994; 62 : 685-91.
19. Jakobsen PH, Hviid L, Theander TG, Afare EA, Ridley RG, Heegaard PM et al. Specific T cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum. Infect Immun 1993; 61 : 268-73.
20. Jones KR, Hickling JK, Targett AT, Playfair HL. Poly clonal in vitro proliferative responses from non-immune donors to Plasmodium falciparum malaria antigens require UCHLI+ (memory) T cells. Eur J Immunol 1990; 20 : 307-15.
21. Fern J, Good MF. Promiscuous malaria peptide epitope stimulates CD45Ra T cells from peripheral blood of non-exposed donors. J Immunol 1992; 148 : 907-13.
22. Langhorne J, Gillard S, Simon B, Slade S, Eichmann K, Frequencies of CD4+ T cells reactive with P. chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol 1989; 1 : 416-24.
23. de Souza JB, Playfair JH. Immunization of mice against blood-stage Plasmodium Yoelii malaria with isoelectrically focussed antigens and correlation of immunity with T-cell priming in vivo. Infect Immun 1988; 56 : 88-91.
24. Perlmann H, Perlmann P. Berzins K, Wåhlin B, Troye-Blomberg M, Hagstedt M et al. Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev 1989; 112 : 115-35.
25. Chougnet C, Troye-Blomerg M, Deloron P, Kabilan L. Lepers JP, Savel J et al. Human immune response in P. falciparum malaria: synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro. J Immunol 1991; 147 : 2295-301.
26. Kumar A, Arora R, Kaur P, Chauhan VS, Sharma P. 'Universal' T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J Immunol 1992; 148:1499-505.
27. Herrera MA, Rosero F, Herrera S, Caspers P, Rotmann D, Sinigaglia F et al. Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma Interferon levels with protection. Infect Immun 1992; 60:154-8.
28. Melloirk S, Green SJ, Nacy CA, Hoffman SL. IFN-gamma inhibits development of P. berghei exoerythrocytic stages in hepatocytes by an L-arginine dependent effector mechanism. J Immunol 1991; 146:3971-76.
29. Ferrante A, Kumaratilake LM, Rzepczyk CM, Dayer JM. Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Immunol Lett 1990; 25:179-87.
30. Kumaratilake LM, Ferrante A. T-cell cytokines in malaria: their role in the regulation of neutrophil- and macrophage-mediated killing of Plasmodium falciparum asexual blood forms. Res Immunol 1994; 145:423-9.
31. Hesselgesser J, Chitnis CE, Miller LH, Yansura DC, Simmons LC, Fairbrother WJ et al. A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J Biol Chem 1995; 270 : 11472-6.
32. Allison AC, Equi EM. The role of cell mediated immune responses in resistance to malaria, with special reference to oxidant stress. Ann Rev Immunol 1983; 1:361-92.
33. Kabilan L, Troye-Blomberg M. Perlmann H. Andersson G, Högh B. Petersen E et al. T-cell epitopes in Pf155/RESA. a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci USA 1988; 85:5659-63.
34. Kabilan L, Troye-Blomberg M, Andersson G. Riley EM, Ekre H-P, Whittle HC et al. Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen. Infect Immun 1990; 58:2989-94.
35. Maheswari RK, Czarniecki CW, Dutta GP, Puri SK, Dhawan BN, Friedman RM. Recombinant human gamma interferon inhibits simian malaria. Infect Immun 1986; 53:628-30.
36. Clark IA, Cowden WB. Roles of TNF in malaria and other parasitic infections. In : B.B. Aggarwal, J.Vilcek, editors. Tumour necrosis factors, structures regulation and functions . New York, Dekker. 1991; 365-407.
37. Allan R, Rowe A, Kwiatkowski D. P. falciparum varies in its ability to induce tumour necrosis factor. Infect Immun 1993; 61:4772-6.
38. Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clerk, IA. In vivo induction of nitrite and nitrate by tumour necrosis factor, lymphotoxin, and interleukin-1 : possible roles in malaria. Infect Immun 1992; 60 : 3725-30.
39. Naotunne T de s, Karunaweera ND, Carter R, Menais KN. Cytokine mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 1993; 78: 555-62.
40. Nussler AK, Renia L, Pasquetto V, Miltgen F, Matile H, Mazier D. In vivo induction of nitric oxide pathway in hepatocytes after injection with irradiated sporozoites or adjuvants. Eur J Immunol 1993; 23 : 882-7.
41. Zhang JH, Ferrante A, Arrigo AP, Dayer JM. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J Immunol 1992; 148:177-81.
42. Bouharoun-Tayoun BH, Oeuvray C, Lunel F, Druilhe P. Mechanism underlying the monocyte-mediated antibody dependent killing of P. falciparum asexual blood stages. J Exp Med 1995; 182:409-18.
43. McGuire W, Hill AVS, Allstop CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF- alpha promotor region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
44. Kabilan L. T cell regulation of immune responses to the P. falciparum antigen Pf155/RESA. PhD thesis, Stockholm University, Sweden. 1990.
45. Reiner SL. Parasites and T helper cell development: some insights. Parasitol Today 1994; 10:485-8.
46. Langhorne J, Simon-Haarhaus B. Differential T cell responses to Plasmodium chabaudi chabaudi in peripheral blood and spleens of C57BL/6 mice during infection. J Immunology 1991; 146:2771-5.
47. Taylor-Robinson AW, Phillips RS. Functional characterization of protective CD4+ T cell clones reactive to the murine malaria parasite P. chabaudi. Immunology 1992; 77:99-105.
48. Troye-Blomberg M, Riley EM, Kabilan L, Holmberg M, Perlmann H, Andersson U et al. Production by activated human T cells of interleukin-4 but not interferon gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci USA 1990; 87:5484-8.
49. Troye-Blomberg M, Olerup O, Perlmann H, Larsson A, Elghazali G, Fogdell A et al. Characterization of regulatory T-cell responses in humans induced by the P. falciparum blood stage antigen Pf155/RESA. Behring Inst Mitt. 1994; 95 : 97-105.
50. Moreno A, Clavijo P, Edelman R, Davis J, Sztein M, Herrington D et at. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int Immunol 1991; 3 : 997-1003.
51. Tsuji M, Romero P, Nussenzweig RS, Zavala F. CD4+cytolytic T cell clones confers protection against murine malaria. J Exp Med 1990; 72:1353-7.
52. Enia L. Grillot D, Marussig M, Corradin G, Miltgen F, Lambert LH et al. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against P.yoelii liver stage. J Immunol 1993; 15:1471-8.
53. Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero P, Maryanski JL et al. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protects against malaria. Int Immunol 1991; 3:579-85.
54. Romero P, Maryanski JL, Cordey AS, Corradin G, Nussenzweig RS, Zavala F. Isolation and charecterization of protective cytolytic T cell in a rodent malaria model system. Immunol Lett 1990; 25: 27-31.
55. Renggli J, Valmori D, Romero JF, Eberl G, Romero P. Betschart B et al. CD8+ T cell protective immunity induced by immunization with P. berghei CS protein derived synthetic peptides: evidence that localization of peptide specific CTLs is crucial for protection against malaria. Immunol Lett 1995; 46:199-205.
56. Enia L, Marussig M, Grillot D, Pied S, Corradin G, Miltgen F et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci 1991; 15:7963-7.
57. Doolan DL, Sedegah M, Hedstrom RC, Hobart B, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunzation: CD8+ cell-, interferon-gamma-, and nitric oxide-dependent immunity. J Exp Med 1996; 183 : 1739-46.
58. Rodrigues EG, Zaval F, Eichinger D, Wilson JM, Tsuji M. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol 1997; 158 : 1268-74.
59. Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD. Houghten RA et al. Recombinant pseudorabies virus carrying a Plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B- cell immunity. Vaccine 1992; 10 : 578-84.
60. Doolan DL, Good MF. P. falciparum CS protein prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation. Mem Inst Oswaldo Cruz 1992; 87:241-7.
61. Doolan DL, Houghten RA, Good MF. Location of human cytotoxic T cell epitopes within a polymorphic domain of the Plasmodium falciparum circumsporozoite protein. Int Immunol 1991; 3:511-6.
62. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL, Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite 35 protein. Proc Natl Acad Sci 1991; 88:3300-4.
63. Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R et al. Safely, immunogenicity, and efficacy of a recombinantly produced Plasmodiumm falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis 1995; 171:1576-85.
64. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352:595-600.
65. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360:434-9.
66. Fell AH, Currier J, Good MF. Inhibition of P. falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite immunol 1994; 16:579-86.
67. Good MF, Zevering Y. Malaria-specific memory T cells: putative roles of different types of memory responses in immunity and disease. Res Immunol 1994; 145:455-60.
68. Good MF, Quaki IA, Saul A, Berzofsky A, Carter R, Miller LH. Genetic control of the immune response in mice to a P. falciparum sporozoite vaccine. Widespread non-responsiveness to a single malaria T epitope in highly repetitive vaccine. J Exp Med 1987; 164 : 655-60
69. Blum-Tirouvanziam U, Servis C, Habluetzel A, Valmori D, Men Y, Esposito F. et al. Localization of HLA2.1 restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J Immunol 1995; 15:3922-31.
70. Troye-Blomberg M, Lepers JP, Sjöberg K, Rahalimalala L, Larsson A, Olerup O, et al. Presentation of the P. falciparum antigen Pf155/RESA to human T cells. Variations in responsiveness induced by antigen presenting cells from different but MHC class II identical donors. Immunol Lett 1994; 43:59-66.
71. Migot F, Chougnet C, Perichon B, Danze PM, Lepers JP, Krishnamoorthy R, et al. Lack of correlation between HLA class II alleles and immune responses to Pf155 ring infected erythrocyte surface antigen (RESA) from Plasmodium falciparum in Madagascar. Am J Trop Med Hyg 1995; 52 : 252-7.
72. Dieye A, Heidrich HG, Rogier C, Trape JF, Launois P, Holder AA, et al. Lynphocyte response to P. falciparum merozoite antigens in donors from a holoendemic area. Parassitologia 1993; 35:35-8.
73. Weidanz WP, Melancon-Kaplan J, Cavacini LA. Cell mediated immunity to the asexual blood stages of malarial parasites: animal models. Immunol Lett 1990; 25:87-95.
74. Kumar S. Gorden J, Flynn JL, Berzofsky JA, Miller LH. Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen. Infect Immun 1990; 58:3425-9.
75. Waki S, Uehara S, Kanbe K, Ono K, Suzuki M, Naruchi H. The role of T cells in pathogenesis and protective immunity to murine malaria. Immunology, 1992; 75:646-51.
76. Van der Heyde HC. Elloso MM, Chang WL, Kaplan M, Manning, DD, Weidanz WP. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J Immunol 1995; 15:3985-90.
77. Good MF. Development of immunity to malaria may not be an entirely active process. Parasite Immunol 1995; 17:55-9.
78. Taylor-Robinson AW, Phillips RS. Reconstitution of B cell depleted mice with B cells restores the Th2-type immune responses during P. chabaudi chabaudi infection. Infect Immun 1996; 64:366-70.
79. Hviid L,Theander TG, Jakobsen PH, Abu-Zeid YA, Abdulhadi NH, Saeed BO et al. Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan, APMIS 1990; 95:594-604.
80. Beck HP, Felger I, Genton B, Alexander N, al-Yaman F. Anders RF et al. Humoral and cell-mediated immunity to the P. falciparum RESA in an adult population exposed to highly endemic malaria. Infect Immun 1995; 63:596-600.
81. Ho M, Webster HK, Looaresuwan S, Supanaranoud RE, Chanthavanich P, Warrell DA. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis 1986; 153:763-71.
82. Ray P, Ansari M.A, Sharma YD. P. vivax: immune responses in a cross-section of the population in the Delhi area of India. Am J Trop Med Hyg 1994; 51:436-43.
83. Goonewardene R, Carter R, Gamage CP, Del Giudice G. David PH. Howie S, et al. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosuppression following prolonged exposure to endemic malaria. Eur J Immunol 1990; 20:1387-91.
84. Mshana RN, Mclean S, Boulandi J. In vitro cell-mediated immue responses to Plasmodium falciparum schizont antigens in adults from a malaria endemic area: CD8+ T lymphocytes inhibit the response of low responder individuals. Int Immunol 1990; 12:1121-32.
85. Theander TG, Hviid L, Abu-Zeid YA, Abdulhadi NH, Saeed BO, Bayoumi RA et al. Activation of CD8+ positive suppressor cells during the malaria season. Immunol Infect Dis 1993; 3 : 97-102.
86. Raybourne R, Desowitz RS, Sanghirun C. Antigen-specific and concanavalin-A induced lymphocyte blastogenesis responses during the course of Plasmodinm berghei infection in rats. Parasite Immunol 1984; 6:435-41.
87. Hviid L, Theander TG. Seasonal changes in human immune responses to malaria. Parasitol Today 1993; 9:26-7.
88. Troye-Blomberg M, Riley EM, Perlmann H, Andersson G, Larsson A, Snow RW et al. T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol 1989; 143:3043-8.
89. Migot F, Chougnet C, Raharimalala L, Astagneau P. Lepers JP, Deloron P. Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/ RESA) after a decrease in malaria transmission in Madagascar. Am J Trop Med Hyg 1993; 48:432-9.
90. Abu-Zeid YA, Abdulhadi NH, Theander TG, Hviid L. Saeed BO, Jepsen S et al. Seasonal changes in cell mediated immune responses to soluble Plasmodium falciparum antigens in children with haemoglobin AA and haemoglobin AS. Trans R Soc Trop Med Hyg 1992; 86:20-2.
91. Nussenzweig V. Nussenzweig R. Sporozoite malaria vaccine. Where do we stand? Ann Parasitol Hum Comp 1990; 65:49-52.
92. Doolan DL, Khamboonruang C, Bcck HP, Houghten RA, Good MF. Cytotoxic T lymphocyte (CTL) low responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int Immunol 1993; 5:37-46.
93. Migliorini P, Boulanger N, Betschart B, Corradin G. Plasmodium herghei subunit vaccine : repeat synthetic peptide of circumsporozoite protein comprising of T- and B-cell epitopes fails to confer immunity. Scand J iiumunol 1990; 37:237-42.
94. Lalvani A, Hurt N, Aidoo M. Kibatala P, Tanner M, Hill AV. Cytotoxic T lymphocytes to P. falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur J immunol 1996; 26:773-9.
95. Golding B, Zaitseva M, Golding H. The potential for recruiting immune responses toward type 1 or type 2 T cell help. Am J Trop Med Hyg 1994; 50:33-40.
96. Kumar P, Ivanov B, Kabilan L, Rao DN. Construction of synthetic immunogen: use of natural immunomodulalor 'Polytuftsin' in malaria vaccines against Plasmodium falciparum. Vaccine. 1994; 12:819-24.